Lataa...
Clinical Perspectives on the Use of Subcutaneous and Oral Formulations of Semaglutide
Early and effective glycemic control can prevent or delay the complications associated with type 2 diabetes (T2D). The benefits of glucagon-like peptide-1 receptor agonists (GLP-1RAs) are becoming increasingly recognized and they now feature prominently in international T2D treatment recommendations...
Tallennettuna:
| Julkaisussa: | Front Endocrinol (Lausanne) |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8276717/ https://ncbi.nlm.nih.gov/pubmed/34267725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.645507 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|